139 related articles for article (PubMed ID: 19451069)
1. Interstitial lung disease associated with oxaliplatin: description of two cases.
Pena Alvarez C; Suh Oh HJ; Sáenz de Miera Rodríguez A; García Arroyo FR; Covela Rúa M; Salgado Boquete L; López Clemente PM; Constenla Figueiras M
Clin Transl Oncol; 2009 May; 11(5):332-3. PubMed ID: 19451069
[No Abstract] [Full Text] [Related]
2. Interstitial lung disease caused by oxaliplatin. An uncommon but not unknown complication.
Sánchez Cendra C; Juez Martel I; Gutierrez Abad D
Arch Bronconeumol; 2017 Apr; 53(4):213-215. PubMed ID: 27756654
[No Abstract] [Full Text] [Related]
3. Interstitial lung diseases in patients treated with oxaliplatin, 5-fluorouracil and leucovorin (FOLFOX).
Jung KH; Kil SY; Choi IK; Seo JH; Shin C; Kim YS; Kim JH
Int J Tuberc Lung Dis; 2006 Oct; 10(10):1181-2. PubMed ID: 17044215
[No Abstract] [Full Text] [Related]
4. [Interstitial lung disease associated with combination chemotherapy of oxaliplatin, 5-fluorouracil, and leucovorin].
Park S; Jung JJ; Kim GB; Yoon HS; Ko SH; Ko JE; Lee YS
Korean J Gastroenterol; 2010 May; 55(5):340-3. PubMed ID: 20697195
[TBL] [Abstract][Full Text] [Related]
5. Interstitial pneumonia arising in a patient treated with oxaliplatin, 5-fluorouracil, and, leucovorin (FOLFOX).
Muneoka K; Shirai Y; Sasaki M; Wakai T; Sakata J; Hatakeyama K
Int J Clin Oncol; 2009 Oct; 14(5):457-9. PubMed ID: 19856057
[TBL] [Abstract][Full Text] [Related]
6. Eosinophilic lung disease under chemotherapy with oxaliplatin for colorectal cancer.
Gagnadoux F; Roiron C; Carrie E; Monnier-Cholley L; Lebeau B
Am J Clin Oncol; 2002 Aug; 25(4):388-90. PubMed ID: 12151971
[TBL] [Abstract][Full Text] [Related]
7. Interstitial pneumonitis after oxaliplatin treatment in colorectal cancer.
Yagüe XH; Soy E; Merino BQ; Puig J; Fabregat MB; Colomer R
Clin Transl Oncol; 2005 Dec; 7(11):515-7. PubMed ID: 16373064
[TBL] [Abstract][Full Text] [Related]
8. Acute interstitial pneumonitis in a patient receiving a FOLFOX-4 regimen plus cetuximab treated with pulse therapy.
Lai JI; Wang WS; Lai YC; Lin PC; Chang SC
Int J Clin Pharmacol Ther; 2010 Jul; 48(7):425-8. PubMed ID: 20557834
[TBL] [Abstract][Full Text] [Related]
9. [Standard chemotherapy for colonic neoplasms].
Hyodo I
Nihon Naika Gakkai Zasshi; 2007 Feb; 96(2):283-8. PubMed ID: 17370594
[No Abstract] [Full Text] [Related]
10. Organizing pneumonia with fatal outcome after adjuvant chemotherapy with FOLFOX.
Vargas A; Montironi C; Buxó E
Arch Bronconeumol; 2015 Nov; 51(11):610. PubMed ID: 26163115
[No Abstract] [Full Text] [Related]
11. Pulmonary toxicity of 5-fluoracil and oxaliplatin.
Ruiz-Casado A; García MD; Racionero MA
Clin Transl Oncol; 2006 Aug; 8(8):624. PubMed ID: 16952855
[No Abstract] [Full Text] [Related]
12. Successful Completion of Adjuvant Chemotherapy in a Patient With Colon Cancer Experiencing 5-Fluorouracil-Induced Cardiac Vasospasm.
Vargo CA; Blazer M; Reardon J; Gulati M; Bekaii-Saab T
Clin Colorectal Cancer; 2016 Jun; 15(2):e61-3. PubMed ID: 26701613
[No Abstract] [Full Text] [Related]
13. Fatal pneumonitis induced by oxaliplatin.
Arévalo Lobera S; Sagastibeltza Mariñelarena N; Elejoste Echeberría I; Melé Olivé M; Egaña Otaño L; Basterretxea Badiola L; La Casta Muñoa A; Azkue Gabilondo M
Clin Transl Oncol; 2008 Nov; 10(11):764-7. PubMed ID: 19015075
[TBL] [Abstract][Full Text] [Related]
14. 'Out of blue' Lhermitte's sign: three cases due to low cumulative doses of oxaliplatin.
Jurado JM; Pajares B; Olmos D; Sevilla I; Alba E
Ann Oncol; 2008 Dec; 19(12):2093-4. PubMed ID: 18977850
[No Abstract] [Full Text] [Related]
15. Prognosis and treatment of FOLFOX therapy related interstitial pneumonia: a plea for multimodal immune modulating therapy in the respiratory insufficient patient.
De Weerdt A; Dendooven A; Snoeckx A; Pen J; Lammens M; Jorens PG
BMC Cancer; 2017 Aug; 17(1):586. PubMed ID: 28851379
[TBL] [Abstract][Full Text] [Related]
16. Idiosyncratic reaction after oxaliplatin: circumvention by use of a continuous infusional administration schedule.
Schüll B; Kornek GV; Scheithauer W
Ann Oncol; 2001 Nov; 12(11):1653-4. PubMed ID: 11822769
[No Abstract] [Full Text] [Related]
17. Oxaliplatin-related hyperammonaemic encephalopathy in a patient with colon cancer.
Chang YY; Lin JK; Jiang JK
Colorectal Dis; 2012 Dec; 14(12):e821. PubMed ID: 22330089
[No Abstract] [Full Text] [Related]
18. Is oxaliplatin combined with weekly bolus 5-fluorouracil and leucovorin an option for stage II and III colon cancer?
Twelves C
Nat Clin Pract Oncol; 2008 Feb; 5(2):72-3. PubMed ID: 18030299
[No Abstract] [Full Text] [Related]
19. Interstitial lung disease associated with FOLFOX chemotherapy.
Lim JH; Kim H; Choi WG; Lee MH
J Cancer Res Ther; 2010; 6(4):546-8. PubMed ID: 21358098
[TBL] [Abstract][Full Text] [Related]
20. Interstitial lung disease following FOLFOX + FOLFIRI and bevacizumab therapy associated with leucovorin: A case report.
Mitsuboshi S; Kozakai H; Yamada H; Nagai K; Furukawa T; Aizawa K
J Oncol Pharm Pract; 2018 Oct; 24(7):540-543. PubMed ID: 28696176
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
